publication venue for
- Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry.. 42. 2023
- Perception of risk and impact of the COVID-19 pandemic on patients with rheumatic diseases: a case-control study. 2022
- Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.. 40. 2021
- Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?. 40. 2020
- Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry.. 39. 2019
- Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.. 38. 2019
- Inflammatory dietary pattern and risk of developing rheumatoid arthritis in women.. 38. 2018
- Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.. 37. 2018
- Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study.. 37. 2018
- Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein.. 37. 2018
- Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry.. 37. 2017
- Economic impact of biologic utilization patterns in patients with psoriatic arthritis.. 36. 2017
- Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.. 36. 2017
- Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group.. 36. 2016
- Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort.. 35. 2016
- Fellow use of medical jargon correlates inversely with patient and observer perceptions of professionalism: results of a rheumatology OSCE (ROSCE) using challenging patient scenarios.. 35. 2015
- Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.. 34. 2015
- A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors.. 34. 2014
- Utility and feasibility of musculoskeletal ultrasonography (MSK US) in rheumatology practice in Canada: needs assessment.. 30. 2011
- Behçet's disease in Lebanon: clinical profile, severity and two-decade comparison.. 25. 2005
- Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies: comment on the article by Sairam et al.. 22. 2003
- Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City. 2022
- Anaphylaxis to anakinra in a pediatric patient with systemic juvenile idiopathic arthritis successfully treated with canakinumab: a case-based review. 2015
- Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity. 2014
- Life-threatening complications of adult-onset Still's disease. 2014
- The practical value of biologics registries in Africa and Middle East: challenges and opportunities. 2012
- The challenge of profound hypoglycorrhachia: two cases of sarcoidosis and review of the literature. 2011
- Biosimilars in rheumatic diseases: structural and functional variability that may impact clinical and regulatory decisions. 2016
- Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. 2004